55 related articles for article (PubMed ID: 12125919)
1. Cyclins D1, E, A expression and synergistic cytotoxicity to a cholangiocarcinoma cell line from recombinant TNF-alpha and PHA supernate.
Vongsakul M; Aksomboon A
Asian Pac J Allergy Immunol; 2002 Mar; 20(1):57-60. PubMed ID: 12125919
[TBL] [Abstract][Full Text] [Related]
2. Synergistic cytotoxicity and apoptosis induced in human cholangiocarcinoma cell lines by a combined treatment with tumor necrosis factor-alpha (TNF-alpha) and triptolide.
Panichakul T; Wanun T; Reutrakul V; Sirisinha S
Asian Pac J Allergy Immunol; 2002 Sep; 20(3):167-73. PubMed ID: 12587840
[TBL] [Abstract][Full Text] [Related]
3. ALCAM is a Novel Cytoplasmic Membrane Protein in TNF-α Stimulated Invasive Cholangiocarcinoma Cells.
Adisakwattana P; Suwandittakul N; Petmitr S; Wongkham S; Sangvanich P; Reamtong O
Asian Pac J Cancer Prev; 2015; 16(9):3849-56. PubMed ID: 25987048
[TBL] [Abstract][Full Text] [Related]
4. Combining cetuximab with killer lymphocytes synergistically inhibits human cholangiocarcinoma cells in vitro.
Morisaki T; Umebayashi M; Kiyota A; Koya N; Tanaka H; Onishi H; Katano M
Anticancer Res; 2012 Jun; 32(6):2249-56. PubMed ID: 22641659
[TBL] [Abstract][Full Text] [Related]
5. Combined targeting of AKT and mTOR using MK-2206 and RAD001 is synergistic in the treatment of cholangiocarcinoma.
Ewald F; Grabinski N; Grottke A; Windhorst S; Nörz D; Carstensen L; Staufer K; Hofmann BT; Diehl F; David K; Schumacher U; Nashan B; Jücker M
Int J Cancer; 2013 Nov; 133(9):2065-76. PubMed ID: 23588885
[TBL] [Abstract][Full Text] [Related]
6. TNF-alpha induces caspase 3 (CPP 32) dependent apoptosis in human cholangiocarcinoma cell line.
Utaisincharoen P; Tangthawornchaikul N; Ubol S; Chaisuriya P; Sirisinha S
Southeast Asian J Trop Med Public Health; 2000; 31 Suppl 1():167-70. PubMed ID: 11414450
[TBL] [Abstract][Full Text] [Related]
7. Inverse correlation of aberrant expression of fragile histidine triad (FHIT) protein with cyclin D1 protein and prognosis in Chinese patients with cholangiocarcinoma.
Zhao P; Lu Y; Zhong M; Liu L; Li B
Acta Oncol; 2008; 47(8):1557-63. PubMed ID: 18618300
[TBL] [Abstract][Full Text] [Related]
8. Molecular chemotherapy combined with radiation therapy enhances killing of cholangiocarcinoma cells in vitro and in vivo.
Pederson LC; Buchsbaum DJ; Vickers SM; Kancharla SR; Mayo MS; Curiel DT; Stackhouse MA
Cancer Res; 1997 Oct; 57(19):4325-32. PubMed ID: 9331094
[TBL] [Abstract][Full Text] [Related]
9. Lovastatin overcomes gefitinib resistance through TNF-α signaling in human cholangiocarcinomas with different LKB1 statuses in vitro and in vivo.
Yang SH; Lin HY; Chang VH; Chen CC; Liu YR; Wang J; Zhang K; Jiang X; Yen Y
Oncotarget; 2015 Sep; 6(27):23857-73. PubMed ID: 26160843
[TBL] [Abstract][Full Text] [Related]
10. Methionine aminopeptidase 2 over-expressed in cholangiocarcinoma: potential for drug target.
Sawanyawisuth K; Wongkham C; Pairojkul C; Saeseow OT; Riggins GJ; Araki N; Wongkham S
Acta Oncol; 2007; 46(3):378-85. PubMed ID: 17450475
[TBL] [Abstract][Full Text] [Related]
11. Inflammation and tumor progression: a lesson from TNF-alpha-dependent FAK signaling in cholangiocarcinoma.
Mon NN; Kokuryo T; Hamaguchi M
Methods Mol Biol; 2009; 512():279-93. PubMed ID: 19347283
[TBL] [Abstract][Full Text] [Related]
12. An oestrogen receptor β-selective agonist exerts anti-neoplastic effects in experimental intrahepatic cholangiocarcinoma.
Marzioni M; Torrice A; Saccomanno S; Rychlicki C; Agostinelli L; Pierantonelli I; Rhönnstad P; Trozzi L; Apelqvist T; Gentile R; Candelaresi C; Fava G; Semeraro R; Benedetti A; Gaudio E; Franchitto A; Onori P; De Minicis S; Carpino G; Kallin E; Alvaro D; Nilsson S
Dig Liver Dis; 2012 Feb; 44(2):134-42. PubMed ID: 21782536
[TBL] [Abstract][Full Text] [Related]
13. [Effect of transforming growth factor alpha on the expression of cyclin E and cyclin D1 in gastric carcinoma cells].
Liang WJ; Zhang WD; Chen CL; Yao YL; Luo RC
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug; 26(8):1255-7. PubMed ID: 16939931
[TBL] [Abstract][Full Text] [Related]
14. Mannoprotein-induced anti-U937 cell cytotoxicity in peripheral blood mononuclear cells from uninfected or HIV-infected subjects: role of interferon-gamma and tumor necrosis factor-alpha.
Gomez MJ; Torosantucci A; Quinti I; Testa U; Peschle C; Cassone A
Cell Immunol; 1993 Dec; 152(2):530-43. PubMed ID: 8258154
[TBL] [Abstract][Full Text] [Related]
15. Synergistic enhancement of the antitumor activity of recombinant human TNF-alpha by recombinant human IFN-gamma.
Taguchi T; Abe S; Nakano K; Matsui Y; Sohmura Y
Cancer Detect Prev; 1988; 12(1-6):105-14. PubMed ID: 3141050
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of concentrations of pro/anti-inflammatory cytokines after complication-free ECRP in cholangiocarcinoma.
Yıldız K; İnce AT; Gangarapu V; Buğdacı MS; Baysal B; Kayar Y; Sarbay Kemik A; Şentürk H
Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():133-7. PubMed ID: 25910291
[TBL] [Abstract][Full Text] [Related]
17. High Glucose Induced Upregulation of Cyclin a Associating with a Short Survival of Patients with Cholangiocarcinoma: A Potential Target for Treatment of Patients with Diabetes Mellitus.
Saengboonmee C; Detarya M; Sangkhamanon S; Sawanyawisuth K; Seubwai W; Wongkham S
Nutr Cancer; 2022; 74(5):1734-1744. PubMed ID: 34353198
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Wnt signaling induces cell apoptosis and suppresses cell proliferation in cholangiocarcinoma cells.
Zhang KS; Zhou Q; Wang YF; Liang LJ
Oncol Rep; 2013 Sep; 30(3):1430-8. PubMed ID: 23799613
[TBL] [Abstract][Full Text] [Related]
19. ZD1839 (IRESSA) stabilizes p27Kip1 and enhances radiosensitivity in cholangiocarcinoma cell lines.
Yabuuchi S; Katayose Y; Oda A; Mizuma M; Shirasou S; Sasaki T; Yamamoto K; Oikawa M; Rikiyama T; Onogawa T; Yoshida H; Ohtuska H; Motoi F; Egawa S; Unno M
Anticancer Res; 2009 Apr; 29(4):1169-80. PubMed ID: 19414361
[TBL] [Abstract][Full Text] [Related]
20. Expression and antitumor effects of TRAIL in human cholangiocarcinoma.
Tanaka S; Sugimachi K; Shirabe K; Shimada M; Wands JR
Hepatology; 2000 Sep; 32(3):523-7. PubMed ID: 10960444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
